Completed PHASE3 INTERVENTIONAL 3-arm NCT00402428

Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared With Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients

Phase 3 Study to Evaluate the Efficacy and Safety of Albumin Interferon Alfa-2b in Combination With Ribavirin Compared With Peginterferon Alfa-2a in Combination With Ribavirin in Interferon Alfa Naive Subjects With CHC Genotype 1. ACHIEVE-1

Sponsor: Human Genome Sciences Inc.

Conditions Chronic Hepatitis C

Interventions Ribavirin albumin interferon alfa-2b peginterferon alfa-2a

Updated 8 times since 2017 Last updated: Aug 1, 2013 Started: Dec 31, 2006 Primary completion: Feb 28, 2009 Completion: Feb 28, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00402428, this PHASE3 trial focuses on Chronic Hepatitis C and remains completed. Sponsored by Human Genome Sciences Inc., it has been updated 8 times since 2006, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Apr 2022 — Jul 2024 [monthly]

Completed PHASE3
Jan 2021 — Apr 2022 [monthly]

Completed PHASE3

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Feb 2017 — Jun 2018 [monthly]

Completed PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Dec 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Human Genome Sciences Inc.
Novartis

Data source: Human Genome Sciences Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Adelaide, Australia , Albuquerque, United States , Annandale, United States , Atlanta, United States , Badalona - Barcelona, Spain , Baltimore, United States , Barcelona, Spain , Berlin, Germany , Bialystok, Poland , Birmingham, United Kingdom and 128 more locations